Global Biopharma Financing Hit a 4-Year High in Q4 2025, Fueled by $200bn in Pharma M&A
Global biopharma financing closed out 2025 on its strongest footing in years: Q4 was among the strongest quarters for financing in over four years, with
Onyx Scientific Invests $2.0M to Expand GMP API Manufacturing Capacity
Onyx Scientific, a small molecule CDMO, is investing more than £1.5 million to expand its GMP facilities and increase capacity for commercial active pharmaceutical ingredient
ProBioGen Expands Transgene Collaboration With AGE1.CR.pIX License
ProBioGen and Transgene have expanded their existing collaboration through an additional license agreement covering ProBioGen’s AGE1.CR.pIX® suspension cell line. Transgene, a biotech company developing virus-based
DuChemBio to Build $25.5M Radiopharmaceutical CDMO Plant in South Korea
DuChemBio plans to build South Korea’s first contract development and manufacturing organization (CDMO) plant dedicated to radiopharmaceuticals, following a 34.3 billion won ($25.5 million) investment
AtomVie Global Radiopharma Opens $160M Radiopharmaceutical CDMO Facility
AtomVie Global Radiopharma has opened its new 72,300-square-foot manufacturing facility in Hamilton, Ontario, following an investment of more than $160 million. The company said the
How EU Sustainability Regulations Are Reshaping CDMO Manufacturing
“Rather than saying that there’s a gap from the industry, I think there’s a listening gap from our governments.” Neha Dave is an independent EU
Cellipont Bioservices Supports Six Cell Therapy Projects Targeting 2026 IND Submissions
Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), said its facility in The Woodlands, Texas, has supported six client projects that are
Northway Biotech Opens $70.94M Cell Therapy CDMO in Lithuania
Northway Biotech has opened a new cell therapy and personalized medicine CDMO facility in Vilnius, Lithuania, following a €61 million investment by Northway Group. The
Curia Global Opens $200M Expanded Manufacturing Campus in New Mexico
Curia Global, Inc. (Curia) has opened its expanded manufacturing campus in Albuquerque, New Mexico, following a $200 million investment. The expansion adds 70,000 square feet
Fortrea Acquires Worldwide Clinical Trials’ Early Phase Division for $45M to Add 200-Bed CPU and GLP Bioanalytical Lab
Fortrea (Nasdaq: FTRE), a leading global CRO, and Worldwide Clinical Trials announced on September 2, 2026, from Durham and Research Triangle Park, North Carolina, that they
